Rank | Gene Set | Z-score |
---|---|---|
1 | cobalamin metabolic process (GO:0009235) | 8.54572168 |
2 | sterol catabolic process (GO:0016127) | 7.96000304 |
3 | cholesterol catabolic process (GO:0006707) | 7.96000304 |
4 | transcytosis (GO:0045056) | 7.93865362 |
5 | intestinal absorption (GO:0050892) | 7.24308950 |
6 | regulation of phospholipase A2 activity (GO:0032429) | 7.19290084 |
7 | peptidyl-proline hydroxylation (GO:0019511) | 7.13774048 |
8 | cysteine metabolic process (GO:0006534) | 6.97599967 |
9 | glycolipid catabolic process (GO:0019377) | 6.95789957 |
10 | negative regulation of digestive system process (GO:0060457) | 6.83345487 |
11 | membrane lipid catabolic process (GO:0046466) | 6.31357339 |
12 | valine metabolic process (GO:0006573) | 6.11321989 |
13 | branched-chain amino acid catabolic process (GO:0009083) | 6.05962416 |
14 | proline biosynthetic process (GO:0006561) | 6.05206789 |
15 | ceramide catabolic process (GO:0046514) | 5.67579535 |
16 | protein hydroxylation (GO:0018126) | 5.51537806 |
17 | branched-chain amino acid metabolic process (GO:0009081) | 5.37098831 |
18 | cellular modified amino acid catabolic process (GO:0042219) | 5.36207206 |
19 | serine family amino acid biosynthetic process (GO:0009070) | 5.10744451 |
20 | zinc ion transport (GO:0006829) | 4.99786386 |
21 | mitochondrial calcium ion transport (GO:0006851) | 4.96094099 |
22 | leukotriene biosynthetic process (GO:0019370) | 4.85051544 |
23 | positive regulation of heat generation (GO:0031652) | 4.83247728 |
24 | COPI coating of Golgi vesicle (GO:0048205) | 4.78169513 |
25 | Golgi transport vesicle coating (GO:0048200) | 4.78169513 |
26 | regulation of fever generation (GO:0031620) | 4.69411287 |
27 | homocysteine metabolic process (GO:0050667) | 4.65750901 |
28 | interferon-gamma secretion (GO:0072643) | 4.59741485 |
29 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.59455658 |
30 | protein maturation by protein folding (GO:0022417) | 4.58490701 |
31 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.53399266 |
32 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.44315301 |
33 | aspartate family amino acid catabolic process (GO:0009068) | 4.44077532 |
34 | signal peptide processing (GO:0006465) | 4.42087385 |
35 | creatine metabolic process (GO:0006600) | 4.30159778 |
36 | neutrophil mediated immunity (GO:0002446) | 4.28204192 |
37 | neutrophil activation involved in immune response (GO:0002283) | 4.26872338 |
38 | positive regulation of nuclease activity (GO:0032075) | 4.24696061 |
39 | L-serine metabolic process (GO:0006563) | 4.20451102 |
40 | glutamine metabolic process (GO:0006541) | 4.17646439 |
41 | proline metabolic process (GO:0006560) | 4.15249245 |
42 | maintenance of protein localization in organelle (GO:0072595) | 4.15145758 |
43 | response to interferon-beta (GO:0035456) | 4.10900348 |
44 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.10055542 |
45 | transepithelial transport (GO:0070633) | 4.07853718 |
46 | coenzyme catabolic process (GO:0009109) | 4.02365475 |
47 | 4-hydroxyproline metabolic process (GO:0019471) | 4.00410179 |
48 | steroid catabolic process (GO:0006706) | 3.99730758 |
49 | cellular response to unfolded protein (GO:0034620) | 3.99070739 |
50 | GDP-mannose metabolic process (GO:0019673) | 3.98040629 |
51 | serine family amino acid metabolic process (GO:0009069) | 3.97833433 |
52 | L-phenylalanine catabolic process (GO:0006559) | 3.96868738 |
53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.96868738 |
54 | regulation of nuclease activity (GO:0032069) | 3.86997139 |
55 | * response to endoplasmic reticulum stress (GO:0034976) | 3.86803340 |
56 | mitochondrion distribution (GO:0048311) | 3.83332004 |
57 | negative T cell selection (GO:0043383) | 3.82983604 |
58 | L-phenylalanine metabolic process (GO:0006558) | 3.81625598 |
59 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.81625598 |
60 | cellular response to topologically incorrect protein (GO:0035967) | 3.79980733 |
61 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.78442915 |
62 | ER-nucleus signaling pathway (GO:0006984) | 3.76494857 |
63 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.73672334 |
64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.72131180 |
65 | regulation of heat generation (GO:0031650) | 3.68122071 |
66 | intestinal epithelial cell development (GO:0060576) | 3.66953481 |
67 | antibacterial humoral response (GO:0019731) | 3.61225345 |
68 | sphingolipid catabolic process (GO:0030149) | 3.60104948 |
69 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.59596141 |
70 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.57410144 |
71 | negative thymic T cell selection (GO:0045060) | 3.55627285 |
72 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.52065942 |
73 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.47859894 |
74 | sulfur amino acid biosynthetic process (GO:0000097) | 3.45749174 |
75 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.39567647 |
76 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.39218334 |
77 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.36933100 |
78 | glycine metabolic process (GO:0006544) | 3.36843795 |
79 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.33719806 |
80 | antimicrobial humoral response (GO:0019730) | 3.33290080 |
81 | macrophage activation involved in immune response (GO:0002281) | 3.32474999 |
82 | neutrophil activation (GO:0042119) | 3.30614825 |
83 | retinoic acid receptor signaling pathway (GO:0048384) | 3.29152373 |
84 | COPII vesicle coating (GO:0048208) | 3.28448235 |
85 | defense response to Gram-positive bacterium (GO:0050830) | 3.26676505 |
86 | hepatocyte apoptotic process (GO:0097284) | 3.26165499 |
87 | alpha-amino acid biosynthetic process (GO:1901607) | 3.24930968 |
88 | myeloid leukocyte mediated immunity (GO:0002444) | 3.24523346 |
89 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.23504898 |
90 | ER overload response (GO:0006983) | 3.23109295 |
91 | cell redox homeostasis (GO:0045454) | 3.22154021 |
92 | response to unfolded protein (GO:0006986) | 3.20967542 |
93 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.20278077 |
94 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.20029752 |
95 | arachidonic acid secretion (GO:0050482) | 3.19284707 |
96 | icosanoid secretion (GO:0032309) | 3.19284707 |
97 | positive T cell selection (GO:0043368) | 3.19152396 |
98 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.19081996 |
99 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.17214571 |
100 | negative regulation of cell killing (GO:0031342) | 3.16748603 |
101 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.16748603 |
102 | peptidyl-asparagine modification (GO:0018196) | 3.16642506 |
103 | phosphatidylserine metabolic process (GO:0006658) | 3.15857794 |
104 | negative regulation of complement activation (GO:0045916) | 3.14191216 |
105 | biotin metabolic process (GO:0006768) | 3.13932098 |
106 | regulation of gamma-delta T cell activation (GO:0046643) | 3.13245218 |
107 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.11864133 |
108 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 3.10671117 |
109 | acute-phase response (GO:0006953) | 3.09908991 |
110 | tetrapyrrole metabolic process (GO:0033013) | 3.09819877 |
111 | response to topologically incorrect protein (GO:0035966) | 3.09441754 |
112 | negative regulation of epidermis development (GO:0045683) | 3.08928031 |
113 | keratinocyte development (GO:0003334) | 3.07578914 |
114 | negative regulation of humoral immune response (GO:0002921) | 3.07568774 |
115 | I-kappaB phosphorylation (GO:0007252) | 3.05936203 |
116 | positive regulation of granulocyte differentiation (GO:0030854) | 3.05685854 |
117 | regulation of keratinocyte differentiation (GO:0045616) | 3.03953469 |
118 | regulation of interleukin-8 secretion (GO:2000482) | 3.03544798 |
119 | endocrine pancreas development (GO:0031018) | 3.02485983 |
120 | monoamine transport (GO:0015844) | 3.01865583 |
121 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.01329710 |
122 | myeloid cell activation involved in immune response (GO:0002275) | 3.01297214 |
123 | glycine transport (GO:0015816) | 2.97029442 |
124 | negative regulation of cell fate commitment (GO:0010454) | 2.97019140 |
125 | polarized epithelial cell differentiation (GO:0030859) | 2.96820171 |
126 | cholesterol transport (GO:0030301) | 2.96307352 |
127 | sterol transport (GO:0015918) | 2.96307352 |
128 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.96285770 |
129 | regulation of oxidative stress-induced cell death (GO:1903201) | 2.94295814 |
130 | sulfur amino acid catabolic process (GO:0000098) | 2.93821081 |
131 | response to protozoan (GO:0001562) | 2.93648980 |
132 | aspartate family amino acid metabolic process (GO:0009066) | 2.93211443 |
133 | protein N-linked glycosylation (GO:0006487) | 2.93106691 |
134 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93060596 |
135 | activated T cell proliferation (GO:0050798) | 2.90622605 |
136 | peptide catabolic process (GO:0043171) | 2.90503253 |
137 | positive regulation of interleukin-2 production (GO:0032743) | 2.87752650 |
138 | negative regulation of protein activation cascade (GO:2000258) | 2.87749355 |
139 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.86099034 |
140 | mast cell activation (GO:0045576) | 2.85393143 |
141 | cellular response to interleukin-15 (GO:0071350) | 2.85338431 |
142 | regulation of regulatory T cell differentiation (GO:0045589) | 2.81914973 |
143 | leukocyte degranulation (GO:0043299) | 2.81301261 |
144 | leukocyte aggregation (GO:0070486) | 2.79409154 |
145 | detection of molecule of bacterial origin (GO:0032490) | 2.78265730 |
146 | granulocyte activation (GO:0036230) | 2.78115312 |
147 | innate immune response in mucosa (GO:0002227) | 2.78091886 |
148 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.77212008 |
149 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.77212008 |
150 | opsonization (GO:0008228) | 2.74813671 |
151 | positive regulation of respiratory burst (GO:0060267) | 2.74396607 |
152 | positive thymic T cell selection (GO:0045059) | 2.71934139 |
153 | tolerance induction (GO:0002507) | 2.69338077 |
154 | B cell receptor signaling pathway (GO:0050853) | 2.69199031 |
155 | cellular response to type I interferon (GO:0071357) | 2.68182223 |
156 | type I interferon signaling pathway (GO:0060337) | 2.68182223 |
157 | response to type I interferon (GO:0034340) | 2.67859364 |
158 | neutrophil chemotaxis (GO:0030593) | 2.67332843 |
159 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.66143105 |
160 | response to nitrosative stress (GO:0051409) | 2.64047295 |
161 | diterpenoid biosynthetic process (GO:0016102) | 2.64009170 |
162 | T cell selection (GO:0045058) | 2.62862397 |
163 | regulation of respiratory burst (GO:0060263) | 2.62348620 |
164 | neutrophil migration (GO:1990266) | 2.62034433 |
165 | regulation of memory T cell differentiation (GO:0043380) | 2.62030384 |
166 | immunoglobulin mediated immune response (GO:0016064) | 2.60625348 |
167 | acute inflammatory response (GO:0002526) | 2.57173850 |
168 | histone mRNA catabolic process (GO:0071044) | 2.56590010 |
169 | alditol phosphate metabolic process (GO:0052646) | 2.56493737 |
170 | response to interleukin-15 (GO:0070672) | 2.56418747 |
171 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.54749979 |
172 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.54084648 |
173 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.54084648 |
174 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.52943377 |
175 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.52943377 |
176 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.51266200 |
177 | regulation of keratinocyte proliferation (GO:0010837) | 2.50886619 |
178 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.50750704 |
179 | positive regulation of mRNA catabolic process (GO:0061014) | 2.50684913 |
180 | phospholipid scrambling (GO:0017121) | 2.50385794 |
181 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.50301990 |
182 | mucosal immune response (GO:0002385) | 2.47641405 |
183 | intestinal cholesterol absorption (GO:0030299) | 17.2981487 |
184 | exocrine pancreas development (GO:0031017) | 16.9383008 |
185 | digestion (GO:0007586) | 14.0042659 |
186 | protein retention in ER lumen (GO:0006621) | 12.3341625 |
187 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 11.4131588 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 7.70215608 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.91640676 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.86399810 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.36384307 |
5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.23709958 |
6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.15200512 |
7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.75463591 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.72720492 |
9 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 3.34855000 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.83420357 |
11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.83400406 |
12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.78454035 |
13 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.70801392 |
14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.63805897 |
15 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52081432 |
16 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.49249555 |
17 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.49249555 |
18 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.49249555 |
19 | MYB_26560356_Chip-Seq_TH2_Human | 2.30189617 |
20 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.23731504 |
21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22676373 |
22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.21603723 |
23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.17658998 |
24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.15750416 |
25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.13653185 |
26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.13519241 |
27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07323287 |
28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.05115752 |
29 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.02214492 |
30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.95761367 |
31 | GATA3_26560356_Chip-Seq_TH2_Human | 1.95103939 |
32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88653743 |
33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86440895 |
34 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.85233935 |
35 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.84480381 |
36 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.81650707 |
37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80580467 |
38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78704515 |
39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.74676904 |
40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74443019 |
41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72977573 |
42 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.71961667 |
43 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70221990 |
44 | MYB_26560356_Chip-Seq_TH1_Human | 1.69388634 |
45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68137146 |
46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64796035 |
47 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63710484 |
48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63165276 |
49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60545920 |
50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59357407 |
51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54911061 |
52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51991971 |
53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51151024 |
54 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.50340812 |
55 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.49980146 |
56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49603293 |
57 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.49451313 |
58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46749971 |
59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.46028879 |
60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44719342 |
61 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.44566489 |
62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42386489 |
63 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41667232 |
64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38664574 |
65 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.35675924 |
66 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.35071377 |
67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.33432777 |
68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32332429 |
69 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.30815225 |
70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.28356767 |
71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28151884 |
72 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27454538 |
73 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27348877 |
74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24922025 |
75 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.24364350 |
76 | P68_20966046_ChIP-Seq_HELA_Human | 1.23847756 |
77 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.23666182 |
78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23300689 |
79 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.23270764 |
80 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.19866296 |
81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19571930 |
82 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.19504584 |
83 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.17440919 |
84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.16633912 |
85 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.15545727 |
86 | ERA_21632823_ChIP-Seq_H3396_Human | 1.15057021 |
87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14869028 |
88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13537816 |
89 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.13181283 |
90 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12571635 |
91 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12525984 |
92 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12037875 |
93 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11653830 |
94 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10397222 |
95 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.10195662 |
96 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.09912717 |
97 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07708675 |
98 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07244540 |
99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06585302 |
100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05119174 |
101 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04302638 |
102 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03934303 |
103 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.03764863 |
104 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03269364 |
105 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.02999800 |
106 | AR_20517297_ChIP-Seq_VCAP_Human | 1.01947935 |
107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01899315 |
108 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.01784495 |
109 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00475442 |
110 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00349144 |
111 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99399374 |
112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99155607 |
113 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99019699 |
114 | MYC_22102868_ChIP-Seq_BL_Human | 0.98629338 |
115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98622054 |
116 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.97861797 |
117 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.97538284 |
118 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.97428796 |
119 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97336682 |
120 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96227591 |
121 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96178215 |
122 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95918857 |
123 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.94874852 |
124 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.94405876 |
125 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94162098 |
126 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93596201 |
127 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.92813525 |
128 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.92794408 |
129 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91251166 |
130 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91076427 |
131 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.90488227 |
132 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90155988 |
133 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.89435431 |
134 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.89435431 |
135 | MAF_26560356_Chip-Seq_TH1_Human | 0.89117374 |
136 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.89037045 |
137 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.88607446 |
138 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.88450474 |
139 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88217837 |
140 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88186812 |
141 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88077900 |
142 | P300_27268052_Chip-Seq_Bcells_Human | 0.87694569 |
143 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.86753664 |
144 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.85939824 |
145 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85919357 |
146 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85913433 |
147 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.84973030 |
148 | UTX_26944678_Chip-Seq_JUKART_Human | 0.84897640 |
149 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84875667 |
150 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.84770098 |
151 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84738966 |
152 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84050337 |
153 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.83890778 |
154 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.83675503 |
155 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.83251817 |
156 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.83126112 |
157 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.82158889 |
158 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81707276 |
159 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80798015 |
160 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.80706397 |
161 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.80261530 |
162 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80095577 |
163 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.79690648 |
164 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.79223844 |
165 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.77604068 |
166 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.77488219 |
167 | GATA3_26560356_Chip-Seq_TH1_Human | 0.77342426 |
168 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.75708790 |
169 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.75291895 |
170 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.74780134 |
171 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.74009967 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005083_abnormal_biliary_tract | 9.74553159 |
2 | MP0001666_abnormal_nutrient_absorption | 9.38163554 |
3 | MP0005365_abnormal_bile_salt | 6.82461164 |
4 | MP0005220_abnormal_exocrine_pancreas | 6.65516809 |
5 | MP0003868_abnormal_feces_composition | 5.06230173 |
6 | MP0005084_abnormal_gallbladder_morpholo | 4.81154910 |
7 | MP0005085_abnormal_gallbladder_physiolo | 3.72331687 |
8 | MP0003195_calcinosis | 3.65494677 |
9 | MP0010386_abnormal_urinary_bladder | 3.49669657 |
10 | MP0003724_increased_susceptibility_to | 3.42771282 |
11 | MP0003300_gastrointestinal_ulcer | 3.38427526 |
12 | MP0002132_abnormal_respiratory_system | 2.88788541 |
13 | MP0001664_abnormal_digestion | 2.64706236 |
14 | MP0003959_abnormal_lean_body | 2.58590074 |
15 | MP0002693_abnormal_pancreas_physiology | 2.55808106 |
16 | MP0001835_abnormal_antigen_presentation | 2.36415233 |
17 | MP0009785_altered_susceptibility_to | 2.16415420 |
18 | MP0005671_abnormal_response_to | 2.16080698 |
19 | MP0001800_abnormal_humoral_immune | 2.01738195 |
20 | MP0002148_abnormal_hypersensitivity_rea | 2.00943253 |
21 | MP0005451_abnormal_body_composition | 1.98457937 |
22 | MP0003436_decreased_susceptibility_to | 1.90732397 |
23 | MP0005000_abnormal_immune_tolerance | 1.85941200 |
24 | MP0005387_immune_system_phenotype | 1.81985042 |
25 | MP0001790_abnormal_immune_system | 1.81985042 |
26 | MP0005025_abnormal_response_to | 1.81227599 |
27 | MP0002723_abnormal_immune_serum | 1.80530101 |
28 | MP0002166_altered_tumor_susceptibility | 1.80430676 |
29 | MP0002139_abnormal_hepatobiliary_system | 1.75916226 |
30 | MP0002420_abnormal_adaptive_immunity | 1.67776783 |
31 | MP0002419_abnormal_innate_immunity | 1.67010569 |
32 | MP0002452_abnormal_antigen_presenting | 1.66061183 |
33 | MP0001819_abnormal_immune_cell | 1.65514952 |
34 | MP0003638_abnormal_response/metabolism_ | 1.64963422 |
35 | MP0005448_abnormal_energy_balance | 1.61450361 |
36 | MP0002277_abnormal_respiratory_mucosa | 1.60340574 |
37 | MP0004043_abnormal_pH_regulation | 1.59541866 |
38 | MP0002163_abnormal_gland_morphology | 1.58063921 |
39 | MP0001944_abnormal_pancreas_morphology | 1.57100705 |
40 | MP0004233_abnormal_muscle_weight | 1.54301149 |
41 | MP0003705_abnormal_hypodermis_morpholog | 1.52377850 |
42 | MP0000685_abnormal_immune_system | 1.44686559 |
43 | MP0002118_abnormal_lipid_homeostasis | 1.39183197 |
44 | MP0005332_abnormal_amino_acid | 1.37538674 |
45 | MP0004264_abnormal_extraembryonic_tissu | 1.36406142 |
46 | MP0000716_abnormal_immune_system | 1.36182266 |
47 | MP0002398_abnormal_bone_marrow | 1.35922666 |
48 | MP0003943_abnormal_hepatobiliary_system | 1.33171597 |
49 | MP0003866_abnormal_defecation | 1.31729516 |
50 | MP0000689_abnormal_spleen_morphology | 1.29736020 |
51 | MP0010234_abnormal_vibrissa_follicle | 1.29521871 |
52 | MP0001873_stomach_inflammation | 1.27954095 |
53 | MP0003878_abnormal_ear_physiology | 1.21187545 |
54 | MP0005377_hearing/vestibular/ear_phenot | 1.21187545 |
55 | MP0002006_tumorigenesis | 1.20421188 |
56 | MP0005165_increased_susceptibility_to | 1.18227276 |
57 | MP0008995_early_reproductive_senescence | 1.14444922 |
58 | MP0001533_abnormal_skeleton_physiology | 1.13103485 |
59 | MP0000703_abnormal_thymus_morphology | 1.12744919 |
60 | MP0002722_abnormal_immune_system | 1.12346176 |
61 | MP0005397_hematopoietic_system_phenotyp | 1.11568879 |
62 | MP0001545_abnormal_hematopoietic_system | 1.11568879 |
63 | MP0000490_abnormal_crypts_of | 1.07800244 |
64 | MP0006082_CNS_inflammation | 1.07221410 |
65 | MP0005408_hypopigmentation | 0.99924439 |
66 | MP0000470_abnormal_stomach_morphology | 0.99578511 |
67 | MP0001853_heart_inflammation | 0.99262516 |
68 | MP0002429_abnormal_blood_cell | 0.98962770 |
69 | MP0005379_endocrine/exocrine_gland_phen | 0.98699170 |
70 | MP0001501_abnormal_sleep_pattern | 0.97965587 |
71 | MP0008004_abnormal_stomach_pH | 0.97303843 |
72 | MP0003950_abnormal_plasma_membrane | 0.96237440 |
73 | MP0001851_eye_inflammation | 0.94881265 |
74 | MP0009278_abnormal_bone_marrow | 0.94452408 |
75 | MP0003806_abnormal_nucleotide_metabolis | 0.93524786 |
76 | MP0003786_premature_aging | 0.89721066 |
77 | MP0009384_cardiac_valve_regurgitation | 0.89107856 |
78 | MP0000383_abnormal_hair_follicle | 0.88483256 |
79 | MP0002078_abnormal_glucose_homeostasis | 0.86738423 |
80 | MP0005535_abnormal_body_temperature | 0.86637514 |
81 | MP0003186_abnormal_redox_activity | 0.84386669 |
82 | MP0000465_gastrointestinal_hemorrhage | 0.84012044 |
83 | MP0000516_abnormal_urinary_system | 0.83397066 |
84 | MP0005367_renal/urinary_system_phenotyp | 0.83397066 |
85 | MP0001756_abnormal_urination | 0.82868361 |
86 | MP0004947_skin_inflammation | 0.82722571 |
87 | MP0009643_abnormal_urine_homeostasis | 0.82476373 |
88 | MP0005058_abnormal_lysosome_morphology | 0.81907000 |
89 | MP0004381_abnormal_hair_follicle | 0.81850631 |
90 | MP0003045_fibrosis | 0.80746232 |
91 | MP0005464_abnormal_platelet_physiology | 0.80207718 |
92 | MP0008438_abnormal_cutaneous_collagen | 0.80165754 |
93 | MP0005310_abnormal_salivary_gland | 0.79266048 |
94 | MP0001764_abnormal_homeostasis | 0.79257523 |
95 | MP0001663_abnormal_digestive_system | 0.78974709 |
96 | MP0002168_other_aberrant_phenotype | 0.78588725 |
97 | MP0004883_abnormal_blood_vessel | 0.78403035 |
98 | MP0005075_abnormal_melanosome_morpholog | 0.77884607 |
99 | MP0002396_abnormal_hematopoietic_system | 0.77288710 |
100 | MP0005360_urolithiasis | 0.75739144 |
101 | MP0005166_decreased_susceptibility_to | 0.75681322 |
102 | MP0008789_abnormal_olfactory_epithelium | 0.74651556 |
103 | MP0006036_abnormal_mitochondrial_physio | 0.73598044 |
104 | MP0009765_abnormal_xenobiotic_induced | 0.73485992 |
105 | MP0005164_abnormal_response_to | 0.72688659 |
106 | MP0005647_abnormal_sex_gland | 0.71475061 |
107 | MP0001765_abnormal_ion_homeostasis | 0.71405007 |
108 | MP0002136_abnormal_kidney_physiology | 0.70586034 |
109 | MP0005670_abnormal_white_adipose | 0.69902997 |
110 | MP0003252_abnormal_bile_duct | 0.69633101 |
111 | MP0004808_abnormal_hematopoietic_stem | 0.68760878 |
112 | MP0003953_abnormal_hormone_level | 0.66379854 |
113 | MP0002089_abnormal_postnatal_growth/wei | 0.66193478 |
114 | MP0003763_abnormal_thymus_physiology | 0.66051047 |
115 | MP0000003_abnormal_adipose_tissue | 0.63536780 |
116 | MP0010329_abnormal_lipoprotein_level | 0.62925477 |
117 | MP0001845_abnormal_inflammatory_respons | 0.61585736 |
118 | MP0000598_abnormal_liver_morphology | 0.61581097 |
119 | MP0005452_abnormal_adipose_tissue | 0.61571244 |
120 | MP0006054_spinal_hemorrhage | 0.58841947 |
121 | MP0000613_abnormal_salivary_gland | 0.58174009 |
122 | MP0009333_abnormal_splenocyte_physiolog | 0.56314991 |
123 | MP0005499_abnormal_olfactory_system | 0.54267219 |
124 | MP0005394_taste/olfaction_phenotype | 0.54267219 |
125 | MP0005381_digestive/alimentary_phenotyp | 0.53845543 |
126 | MP0002138_abnormal_hepatobiliary_system | 0.53634382 |
127 | MP0003191_abnormal_cellular_cholesterol | 0.52139401 |
128 | MP0005319_abnormal_enzyme/_coenzyme | 0.51620653 |
129 | MP0000609_abnormal_liver_physiology | 0.49042967 |
130 | MP0001731_abnormal_postnatal_growth | 0.46147996 |
131 | MP0003656_abnormal_erythrocyte_physiolo | 0.46118612 |
132 | MP0000371_diluted_coat_color | 0.45508955 |
133 | MP0000750_abnormal_muscle_regeneration | 0.45109015 |
134 | MP0002098_abnormal_vibrissa_morphology | 0.45053957 |
135 | MP0008872_abnormal_physiological_respon | 0.41318929 |
136 | MP0008961_abnormal_basal_metabolism | 0.40590719 |
137 | MP0000367_abnormal_coat/_hair | 0.39492409 |
138 | MP0003795_abnormal_bone_structure | 0.39355101 |
139 | MP0008469_abnormal_protein_level | 0.38867506 |
140 | MP0002928_abnormal_bile_duct | 0.37367433 |
141 | MP0005334_abnormal_fat_pad | 0.37156500 |
142 | MP0005375_adipose_tissue_phenotype | 0.36207042 |
143 | MP0002796_impaired_skin_barrier | 0.34954220 |
144 | MP0000377_abnormal_hair_follicle | 0.33657802 |
145 | MP0009642_abnormal_blood_homeostasis | 0.32906984 |
146 | MP0002060_abnormal_skin_morphology | 0.32100056 |
147 | MP0002876_abnormal_thyroid_physiology | 0.30951874 |
148 | MP0001348_abnormal_lacrimal_gland | 0.30722339 |
149 | MP0010678_abnormal_skin_adnexa | 0.29947478 |
150 | MP0002405_respiratory_system_inflammati | 0.28148577 |
151 | MP0005386_behavior/neurological_phenoty | 0.27359327 |
152 | MP0004924_abnormal_behavior | 0.27359327 |
153 | MP0009763_increased_sensitivity_to | 0.27017616 |
154 | MP0010155_abnormal_intestine_physiology | 0.26881946 |
155 | MP0003956_abnormal_body_size | 0.23792364 |
156 | MP0005636_abnormal_mineral_homeostasis | 0.23650587 |
157 | MP0002069_abnormal_eating/drinking_beha | 0.23650222 |
158 | MP0000920_abnormal_myelination | 0.22820541 |
159 | MP0002075_abnormal_coat/hair_pigmentati | 0.21944351 |
160 | MP0000647_abnormal_sebaceous_gland | 0.21409583 |
161 | MP0004185_abnormal_adipocyte_glucose | 0.20106196 |
162 | MP0000955_abnormal_spinal_cord | 0.19267381 |
163 | MP0003329_amyloid_beta_deposits | 0.18334736 |
164 | MP0000858_altered_metastatic_potential | 0.18132165 |
165 | MP0001186_pigmentation_phenotype | 0.17969029 |
166 | MP0006035_abnormal_mitochondrial_morpho | 0.17881511 |
167 | MP0009931_abnormal_skin_appearance | 0.17400457 |
168 | MP0008875_abnormal_xenobiotic_pharmacok | 0.15899534 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Steatorrhea (HP:0002570) | 9.15966670 |
2 | Fat malabsorption (HP:0002630) | 7.39927730 |
3 | Short chin (HP:0000331) | 6.92164223 |
4 | Decreased subcutaneous fat (HP:0001002) | 6.25776944 |
5 | Abnormality of subcutaneous fat tissue (HP:0001001) | 5.74796988 |
6 | Type I diabetes mellitus (HP:0100651) | 5.63592845 |
7 | Gout (HP:0001997) | 5.54876247 |
8 | Abnormality of the intrinsic pathway (HP:0010989) | 5.23682694 |
9 | Maternal diabetes (HP:0009800) | 4.92034812 |
10 | Exocrine pancreatic insufficiency (HP:0001738) | 4.82559995 |
11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.53317452 |
12 | Hypoplasia of the pons (HP:0012110) | 4.37310117 |
13 | Premature skin wrinkling (HP:0100678) | 4.27764746 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.26528886 |
15 | Hypoproteinemia (HP:0003075) | 4.23626768 |
16 | Abnormality of the pons (HP:0007361) | 4.18465890 |
17 | Pancreatitis (HP:0001733) | 4.10085300 |
18 | Stomatitis (HP:0010280) | 4.04322794 |
19 | Joint stiffness (HP:0001387) | 3.99859082 |
20 | Cortical dysplasia (HP:0002539) | 3.81378287 |
21 | Ketosis (HP:0001946) | 3.78940601 |
22 | Panhypogammaglobulinemia (HP:0003139) | 3.77159133 |
23 | Tubulointerstitial nephritis (HP:0001970) | 3.65735780 |
24 | Abnormality of chloride homeostasis (HP:0011422) | 3.59747690 |
25 | Carpal bone hypoplasia (HP:0001498) | 3.47989131 |
26 | Recurrent fungal infections (HP:0002841) | 3.32071927 |
27 | Hyperglycinemia (HP:0002154) | 3.24542058 |
28 | Long foot (HP:0001833) | 3.23531808 |
29 | Ketoacidosis (HP:0001993) | 3.22510462 |
30 | Eczematoid dermatitis (HP:0000976) | 3.21511070 |
31 | Abnormality of the nasal septum (HP:0000419) | 3.21254188 |
32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.17067034 |
33 | Optic nerve hypoplasia (HP:0000609) | 3.15478866 |
34 | Abnormal protein glycosylation (HP:0012346) | 3.13027295 |
35 | Abnormal glycosylation (HP:0012345) | 3.13027295 |
36 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.13027295 |
37 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.13027295 |
38 | Methylmalonic aciduria (HP:0012120) | 3.07520630 |
39 | Myositis (HP:0100614) | 3.07256887 |
40 | Abnormality of the common coagulation pathway (HP:0010990) | 3.05836977 |
41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.02856422 |
42 | Recurrent cutaneous fungal infections (HP:0011370) | 3.02843711 |
43 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.02843711 |
44 | Abnormal pancreas size (HP:0012094) | 3.00820698 |
45 | Reduced antithrombin III activity (HP:0001976) | 2.95010871 |
46 | Hypoglycemic coma (HP:0001325) | 2.94053280 |
47 | Autoimmune hemolytic anemia (HP:0001890) | 2.91973626 |
48 | Pustule (HP:0200039) | 2.90384449 |
49 | Ileus (HP:0002595) | 2.79719866 |
50 | Hyperglycinuria (HP:0003108) | 2.77219025 |
51 | Tubulointerstitial fibrosis (HP:0005576) | 2.77129849 |
52 | Prenatal maternal abnormality (HP:0002686) | 2.76847138 |
53 | Stomach cancer (HP:0012126) | 2.74614908 |
54 | Abnormality of methionine metabolism (HP:0010901) | 2.73434677 |
55 | Abnormality of dental color (HP:0011073) | 2.72273049 |
56 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.71044043 |
57 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.70891805 |
58 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.70891805 |
59 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.70468587 |
60 | Abnormality of glycine metabolism (HP:0010895) | 2.70468587 |
61 | Fatigue (HP:0012378) | 2.69668861 |
62 | T lymphocytopenia (HP:0005403) | 2.68401469 |
63 | Abnormality of T cell number (HP:0011839) | 2.65113012 |
64 | Congenital stationary night blindness (HP:0007642) | 2.65060099 |
65 | Abnormality of macrophages (HP:0004311) | 2.64407124 |
66 | Severe combined immunodeficiency (HP:0004430) | 2.63790241 |
67 | Metabolic alkalosis (HP:0200114) | 2.62404817 |
68 | Hypokalemic alkalosis (HP:0001949) | 2.57866796 |
69 | Abnormality of the pleura (HP:0002103) | 2.57026171 |
70 | Increased purine levels (HP:0004368) | 2.56598154 |
71 | Hyperuricemia (HP:0002149) | 2.56598154 |
72 | Abnormality of homocysteine metabolism (HP:0010919) | 2.56172305 |
73 | Homocystinuria (HP:0002156) | 2.56172305 |
74 | Widely spaced teeth (HP:0000687) | 2.55945265 |
75 | Abnormal tarsal ossification (HP:0008369) | 2.55606785 |
76 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.55246939 |
77 | Tongue fasciculations (HP:0001308) | 2.55224870 |
78 | Agammaglobulinemia (HP:0004432) | 2.51879716 |
79 | Abnormality of T cells (HP:0002843) | 2.51080477 |
80 | Encephalitis (HP:0002383) | 2.48987175 |
81 | Abnormality of T cell physiology (HP:0011840) | 2.47754716 |
82 | Acute hepatic failure (HP:0006554) | 2.46987581 |
83 | Dicarboxylic aciduria (HP:0003215) | 2.46187675 |
84 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.46187675 |
85 | Muscle fibrillation (HP:0010546) | 2.38701606 |
86 | Small epiphyses (HP:0010585) | 2.37760380 |
87 | Opisthotonus (HP:0002179) | 2.36705144 |
88 | Recurrent abscess formation (HP:0002722) | 2.36283827 |
89 | Mitral stenosis (HP:0001718) | 2.35879507 |
90 | Recurrent bacterial skin infections (HP:0005406) | 2.35432520 |
91 | Vacuolated lymphocytes (HP:0001922) | 2.35385009 |
92 | Pectus carinatum (HP:0000768) | 2.35188219 |
93 | Recurrent skin infections (HP:0001581) | 2.35163805 |
94 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.33204177 |
95 | Optic neuritis (HP:0100653) | 2.33021678 |
96 | Retrobulbar optic neuritis (HP:0100654) | 2.33021678 |
97 | Thoracic kyphosis (HP:0002942) | 2.30384867 |
98 | Thyroiditis (HP:0100646) | 2.29706840 |
99 | IgG deficiency (HP:0004315) | 2.29573920 |
100 | Progressive muscle weakness (HP:0003323) | 2.29244661 |
101 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.29110093 |
102 | Joint swelling (HP:0001386) | 2.28956938 |
103 | Abnormality of macular pigmentation (HP:0008002) | 2.28664174 |
104 | Acute encephalopathy (HP:0006846) | 2.26730431 |
105 | Type I transferrin isoform profile (HP:0003642) | 2.23965622 |
106 | Beaking of vertebral bodies (HP:0004568) | 2.23799174 |
107 | Redundant skin (HP:0001582) | 2.23379118 |
108 | Myocardial infarction (HP:0001658) | 2.22453382 |
109 | Pulmonary fibrosis (HP:0002206) | 2.21517849 |
110 | Hyperactive renin-angiotensin system (HP:0000841) | 2.20163696 |
111 | Orchitis (HP:0100796) | 2.19447429 |
112 | Inflammation of the large intestine (HP:0002037) | 2.19382138 |
113 | Recurrent viral infections (HP:0004429) | 2.16032662 |
114 | Hypoplasia of the odontoid process (HP:0003311) | 2.15401428 |
115 | Abnormality of the prostate (HP:0008775) | 2.14347725 |
116 | Abnormality of B cell number (HP:0010975) | 2.13124029 |
117 | Large hands (HP:0001176) | 2.10454653 |
118 | Cerebral edema (HP:0002181) | 2.07939947 |
119 | Disproportionate short-trunk short stature (HP:0003521) | 2.07267503 |
120 | Increased CSF protein (HP:0002922) | 2.07022576 |
121 | Recurrent bronchitis (HP:0002837) | 2.06596396 |
122 | Chronic hepatic failure (HP:0100626) | 2.06119204 |
123 | Colitis (HP:0002583) | 2.06072006 |
124 | Central scotoma (HP:0000603) | 2.05891124 |
125 | Type II lissencephaly (HP:0007260) | 2.05118826 |
126 | Meningitis (HP:0001287) | 2.05029156 |
127 | Albinism (HP:0001022) | 2.02553054 |
128 | Prostate neoplasm (HP:0100787) | 2.01563791 |
129 | Male infertility (HP:0003251) | 2.01392097 |
130 | Azoospermia (HP:0000027) | 2.01389030 |
131 | Hyperaldosteronism (HP:0000859) | 1.98964557 |
132 | Pulmonary infiltrates (HP:0002113) | 1.98579235 |
133 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.97975165 |
134 | Barrel-shaped chest (HP:0001552) | 1.97562703 |
135 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.96913087 |
136 | Recurrent pneumonia (HP:0006532) | 1.96023047 |
137 | Hyperammonemia (HP:0001987) | 1.95001637 |
138 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.94630394 |
139 | Congenital glaucoma (HP:0001087) | 1.94440588 |
140 | Hypoglycemic seizures (HP:0002173) | 1.94337870 |
141 | Hypochromic microcytic anemia (HP:0004840) | 1.94189405 |
142 | Gastrointestinal inflammation (HP:0004386) | 1.93792969 |
143 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.93663043 |
144 | Enlarged kidneys (HP:0000105) | 1.93542503 |
145 | Villous atrophy (HP:0011473) | 1.93459765 |
146 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.93459765 |
147 | Abnormality of the thoracic spine (HP:0100711) | 1.93396698 |
148 | Vasculitis (HP:0002633) | 1.93375708 |
149 | Abnormality of the lumbar spine (HP:0100712) | 1.92295961 |
150 | Dysostosis multiplex (HP:0000943) | 1.92250573 |
151 | Posterior subcapsular cataract (HP:0007787) | 1.91786524 |
152 | Increased IgE level (HP:0003212) | 1.91093811 |
153 | Cortical visual impairment (HP:0100704) | 1.90636194 |
154 | Chronic otitis media (HP:0000389) | 1.89370401 |
155 | Viral hepatitis (HP:0006562) | 1.89182162 |
156 | Abnormality of eosinophils (HP:0001879) | 1.86230291 |
157 | Lethargy (HP:0001254) | 1.85995168 |
158 | Glucose intolerance (HP:0000833) | 1.84608183 |
159 | Eosinophilia (HP:0001880) | 1.84110471 |
160 | Hypoplasia of the uterus (HP:0000013) | 1.83600674 |
161 | Constricted visual fields (HP:0001133) | 1.83374682 |
162 | Infantile muscular hypotonia (HP:0008947) | 1.82921809 |
163 | Metaphyseal dysplasia (HP:0100255) | 1.82031649 |
164 | Alveolar cell carcinoma (HP:0006519) | 1.81239831 |
165 | Mediastinal lymphadenopathy (HP:0100721) | 1.80093517 |
166 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.79558622 |
167 | Coxa valga (HP:0002673) | 1.79437938 |
168 | Abnormality of the renal cortex (HP:0011035) | 1.79064838 |
169 | Granulocytopenia (HP:0001913) | 1.78363561 |
170 | Abnormality of renin-angiotensin system (HP:0000847) | 1.78156673 |
171 | Renal cortical cysts (HP:0000803) | 1.78140462 |
172 | B lymphocytopenia (HP:0010976) | 1.77652118 |
173 | Decreased circulating renin level (HP:0003351) | 1.77612795 |
174 | Median cleft lip (HP:0000161) | 1.77481558 |
175 | Amelogenesis imperfecta (HP:0000705) | 1.77164324 |
176 | Tubular atrophy (HP:0000092) | 1.77068412 |
177 | Abnormal foot bone ossification (HP:0010675) | 1.76848395 |
178 | Vascular calcification (HP:0004934) | 1.75461763 |
179 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.75198312 |
180 | Generalized aminoaciduria (HP:0002909) | 1.72386711 |
181 | Late onset (HP:0003584) | 1.71425527 |
182 | Hypokinesia (HP:0002375) | 1.71308783 |
183 | Periodontitis (HP:0000704) | 1.70755881 |
184 | Menorrhagia (HP:0000132) | 1.70496086 |
185 | Abnormality of the odontoid process (HP:0003310) | 1.70083571 |
186 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.68967482 |
187 | Abnormality of purine metabolism (HP:0004352) | 1.68011390 |
188 | Renal salt wasting (HP:0000127) | 1.66838905 |
189 | Limb hypertonia (HP:0002509) | 1.65318094 |
Rank | Gene Set | Z-score |
---|---|---|
1 | LMTK2 | 6.43119454 |
2 | ERN1 | 5.46547769 |
3 | EIF2AK3 | 4.48801219 |
4 | MST4 | 4.46396586 |
5 | MAP2K2 | 4.06676477 |
6 | BMPR1B | 3.62983953 |
7 | PKN2 | 2.96689598 |
8 | CDK8 | 2.70947510 |
9 | TRIB3 | 2.67528259 |
10 | MAPKAPK3 | 2.51886304 |
11 | TXK | 2.44057307 |
12 | EEF2K | 2.37307798 |
13 | FRK | 2.30263431 |
14 | ZAP70 | 2.13837556 |
15 | BCKDK | 10.2094328 |
16 | NME2 | 1.97947359 |
17 | TEC | 1.95907261 |
18 | INSRR | 1.92007823 |
19 | MAP3K3 | 1.83352900 |
20 | SIK3 | 1.83128053 |
21 | IRAK3 | 1.72160288 |
22 | FES | 1.68418032 |
23 | TGFBR1 | 1.63062299 |
24 | MAP2K1 | 1.61109622 |
25 | PIK3CA | 1.59879577 |
26 | JAK1 | 1.58256031 |
27 | IKBKB | 1.56062892 |
28 | PAK2 | 1.53664604 |
29 | ACVR1B | 1.51674791 |
30 | RPS6KB2 | 1.45252687 |
31 | RIPK4 | 1.44768610 |
32 | EPHA2 | 1.44485378 |
33 | ITK | 1.43942898 |
34 | SCYL2 | 1.39913884 |
35 | GRK6 | 1.37599783 |
36 | BLK | 1.36566914 |
37 | PASK | 1.35775904 |
38 | GRK1 | 1.29162929 |
39 | DYRK1A | 1.28266573 |
40 | MAP3K12 | 1.25009125 |
41 | PRKCQ | 1.19664187 |
42 | FLT3 | 1.19084296 |
43 | PIK3CG | 1.18025292 |
44 | NME1 | 1.17175351 |
45 | BTK | 1.15606698 |
46 | CDK19 | 1.14171619 |
47 | PRKG2 | 1.13651038 |
48 | PDK2 | 1.12339344 |
49 | OXSR1 | 1.09141155 |
50 | SYK | 1.07784865 |
51 | NEK6 | 1.05557928 |
52 | TAOK3 | 1.03784122 |
53 | BMPR2 | 1.00209466 |
54 | CSK | 0.96945400 |
55 | CDK9 | 0.96416213 |
56 | WNK4 | 0.95429105 |
57 | KIT | 0.95286692 |
58 | IRAK4 | 0.94922735 |
59 | PDGFRB | 0.94559612 |
60 | TNK2 | 0.93841394 |
61 | STK10 | 0.93575050 |
62 | LCK | 0.91119211 |
63 | NLK | 0.90476766 |
64 | PTK6 | 0.86332852 |
65 | MAP2K6 | 0.86155947 |
66 | CAMKK1 | 0.84086831 |
67 | MAPK12 | 0.83535628 |
68 | LYN | 0.82331575 |
69 | HIPK2 | 0.81245444 |
70 | MARK3 | 0.80130314 |
71 | SIK1 | 0.79108062 |
72 | TRIM28 | 0.77269398 |
73 | STK39 | 0.75754599 |
74 | MAPK15 | 0.74234018 |
75 | IKBKE | 0.73815787 |
76 | STK38 | 0.73411908 |
77 | RPS6KB1 | 0.71629788 |
78 | PINK1 | 0.71274030 |
79 | JAK3 | 0.69843530 |
80 | FER | 0.68404663 |
81 | PDK1 | 0.61487019 |
82 | HCK | 0.61434338 |
83 | IRAK2 | 0.59967118 |
84 | FGR | 0.59389469 |
85 | MTOR | 0.56561700 |
86 | LATS1 | 0.56532045 |
87 | PDPK1 | 0.55646609 |
88 | BRD4 | 0.53998458 |
89 | MAP2K3 | 0.53599997 |
90 | CSF1R | 0.53157302 |
91 | MAP4K1 | 0.52860514 |
92 | CAMKK2 | 0.52558894 |
93 | DAPK2 | 0.49472572 |
94 | GRK5 | 0.48967467 |
95 | MUSK | 0.47427190 |
96 | BRSK2 | 0.44568198 |
97 | CHUK | 0.43780281 |
98 | LRRK2 | 0.42242925 |
99 | FGFR3 | 0.42037755 |
100 | TBK1 | 0.41571173 |
101 | PRKCZ | 0.39465611 |
102 | MAPK3 | 0.37005380 |
103 | MELK | 0.36983653 |
104 | STK24 | 0.36613279 |
105 | ERBB2 | 0.35910531 |
106 | MAP3K9 | 0.35593273 |
107 | BCR | 0.35049072 |
108 | DYRK2 | 0.35042226 |
109 | RET | 0.34527676 |
110 | FGFR2 | 0.34241401 |
111 | TYK2 | 0.33975355 |
112 | MAPKAPK5 | 0.33388043 |
113 | TLK1 | 0.32893056 |
114 | STK3 | 0.32858289 |
115 | ILK | 0.32629626 |
116 | PRKACB | 0.31975516 |
117 | PRKCH | 0.31857461 |
118 | DYRK1B | 0.31440803 |
119 | PRKCE | 0.31142045 |
120 | ROCK1 | 0.30627373 |
121 | NEK9 | 0.28659921 |
122 | MAPK11 | 0.27325473 |
123 | DAPK1 | 0.27092548 |
124 | PIM2 | 0.27081779 |
125 | PRKAA2 | 0.26996380 |
126 | MATK | 0.26931150 |
127 | PRKCI | 0.26596073 |
128 | PAK3 | 0.26067811 |
129 | TRPM7 | 0.25724240 |
130 | RPS6KA1 | 0.24908908 |
131 | MAP3K8 | 0.22672337 |
132 | MAP2K7 | 0.21883165 |
133 | ABL1 | 0.21815170 |
134 | MAP3K7 | 0.21794386 |
135 | ADRBK2 | 0.21607574 |
136 | RAF1 | 0.21083025 |
137 | TGFBR2 | 0.18451409 |
138 | JAK2 | 0.17522462 |
139 | CSNK1G3 | 0.17472574 |
140 | IRAK1 | 0.15485538 |
141 | PTK2 | 0.14773416 |
142 | PRKD1 | 0.14340326 |
143 | PDK4 | 0.14067785 |
144 | PDK3 | 0.14067785 |
145 | STK16 | 0.13499598 |
146 | MAPK1 | 0.13166924 |
147 | NUAK1 | 0.12133041 |
148 | CSNK1A1L | 0.11302907 |
149 | CAMK1D | 0.11222946 |
150 | AKT1 | 0.10844056 |
151 | CSNK1G2 | 0.09086008 |
152 | IGF1R | 0.08941763 |
153 | KSR2 | 0.07521290 |
154 | EGFR | 0.06921843 |
155 | MAP3K14 | 0.06915108 |
156 | PIM1 | 0.06896453 |
157 | MAP3K2 | 0.06260381 |
158 | MAPK7 | 0.06197777 |
159 | EPHB1 | 0.06037637 |
160 | CSNK1G1 | 0.04861507 |
161 | MAPKAPK2 | 0.04749568 |
162 | RPS6KA5 | 0.04696136 |
163 | MAP3K1 | 0.04146821 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Pancreatic secretion_Homo sapiens_hsa04972 | 8.36353100 |
2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.90893874 |
3 | Protein digestion and absorption_Homo sapiens_hsa04974 | 5.54187722 |
4 | Protein export_Homo sapiens_hsa03060 | 3.59832278 |
5 | Folate biosynthesis_Homo sapiens_hsa00790 | 3.19203736 |
6 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.94355806 |
7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.88406173 |
8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.83952933 |
9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.73982866 |
10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.50728829 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.28260413 |
12 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.11181791 |
13 | Allograft rejection_Homo sapiens_hsa05330 | 2.03126182 |
14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01586771 |
15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98276707 |
16 | Asthma_Homo sapiens_hsa05310 | 1.98118814 |
17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.94700848 |
18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.93339348 |
19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.93077588 |
20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89575211 |
21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.81596708 |
22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79848924 |
23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54809633 |
24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53497215 |
25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50643246 |
26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.45688034 |
27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45476821 |
28 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.41636421 |
29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32109811 |
30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31676590 |
31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30648986 |
32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.30461872 |
33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.29548498 |
34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.27598100 |
35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.24802075 |
36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.18897734 |
37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.16479030 |
38 | Measles_Homo sapiens_hsa05162 | 1.15463066 |
39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.12108276 |
40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08082988 |
41 | Tuberculosis_Homo sapiens_hsa05152 | 1.04585269 |
42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.04539789 |
43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03793514 |
44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03207339 |
45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.02629891 |
46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98092479 |
47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96882439 |
48 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94849628 |
49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94757543 |
50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.93134551 |
51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91946062 |
52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91923373 |
53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.91775154 |
54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90791084 |
55 | Influenza A_Homo sapiens_hsa05164 | 0.88936716 |
56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88388259 |
57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87862162 |
58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86027277 |
59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85685289 |
60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83957429 |
61 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.83509076 |
62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82689803 |
63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79473797 |
64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77379729 |
65 | Proteasome_Homo sapiens_hsa03050 | 0.74620820 |
66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74549415 |
67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73738423 |
68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72097866 |
69 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70248887 |
70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69786475 |
71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69265613 |
72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68755509 |
73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68344631 |
74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67834572 |
75 | Phototransduction_Homo sapiens_hsa04744 | 0.66868461 |
76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.64743056 |
77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60315661 |
78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57044914 |
79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.56876920 |
80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56488925 |
81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55052713 |
82 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54575918 |
83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53654430 |
84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.52252054 |
85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51379202 |
86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49596155 |
87 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49270902 |
88 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48292452 |
89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47669418 |
90 | Ribosome_Homo sapiens_hsa03010 | 0.46732016 |
91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46316994 |
92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45249311 |
93 | ABC transporters_Homo sapiens_hsa02010 | 0.45182906 |
94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45067142 |
95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44366565 |
96 | Legionellosis_Homo sapiens_hsa05134 | 0.43710630 |
97 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42417386 |
98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41176027 |
99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40278517 |
100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39927293 |
101 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39376288 |
102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39243054 |
103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.38826084 |
104 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38794978 |
105 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38712427 |
106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38489861 |
107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.38452633 |
108 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38245541 |
109 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.36993363 |
110 | Malaria_Homo sapiens_hsa05144 | 0.36819017 |
111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35835784 |
112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35678947 |
113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34213008 |
114 | Insulin secretion_Homo sapiens_hsa04911 | 0.33517025 |
115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33005999 |
116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31925998 |
117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31724792 |
118 | Pertussis_Homo sapiens_hsa05133 | 0.29387044 |
119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28631227 |
120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.28365006 |
121 | Carbon metabolism_Homo sapiens_hsa01200 | 0.28258428 |
122 | RNA degradation_Homo sapiens_hsa03018 | 0.27878094 |
123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24563826 |
124 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.21535687 |
125 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19873781 |
126 | Lysosome_Homo sapiens_hsa04142 | 0.18893554 |
127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.18830185 |
128 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.16184993 |
129 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.15948144 |
130 | Peroxisome_Homo sapiens_hsa04146 | 0.15902642 |
131 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.14626717 |
132 | Histidine metabolism_Homo sapiens_hsa00340 | 0.14143093 |
133 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.12910124 |
134 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.12505391 |
135 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.11992224 |
136 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.11623671 |
137 | Endometrial cancer_Homo sapiens_hsa05213 | 0.11140986 |
138 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.10980645 |
139 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10345180 |
140 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.08341820 |
141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08201874 |
142 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.06400075 |
143 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.04890505 |
144 | Viral myocarditis_Homo sapiens_hsa05416 | 0.03899803 |
145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.02181348 |
146 | Prostate cancer_Homo sapiens_hsa05215 | 0.01893638 |
147 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.01714681 |
148 | Bile secretion_Homo sapiens_hsa04976 | -0.0506319 |
149 | Pancreatic cancer_Homo sapiens_hsa05212 | -0.0479352 |
150 | Platelet activation_Homo sapiens_hsa04611 | -0.0471858 |
151 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0417678 |
152 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0401846 |
153 | Hepatitis C_Homo sapiens_hsa05160 | -0.0155856 |
154 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.0041973 |